- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Antisense oligonucleotide therapeutic approach for Timothy syndrome ; volume:628 ; number:8009 ; day:24 ; month:4 ; year:2024 ; pages:818-825 ; date:4.2024
Nature; 628, Heft 8009 (24.4.2024), 818-825, 4.2024
- Creator
-
Chen, Xiaoyu
Birey, Fikri
Li, Min-Yin
Revah, Omer
Levy, Rebecca
Thete, Mayuri Vijay
Reis, Noah
Kaganovsky, Konstantin
Onesto, Massimo
Sakai, Noriaki
Hudacova, Zuzana
Hao, Jin
Meng, Xiangling
Nishino, Seiji
Huguenard, John
Pașca, Sergiu P.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41586-024-07310-6
- URN
-
urn:nbn:de:101:1-2407180747048.758873341379
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chen, Xiaoyu
- Birey, Fikri
- Li, Min-Yin
- Revah, Omer
- Levy, Rebecca
- Thete, Mayuri Vijay
- Reis, Noah
- Kaganovsky, Konstantin
- Onesto, Massimo
- Sakai, Noriaki
- Hudacova, Zuzana
- Hao, Jin
- Meng, Xiangling
- Nishino, Seiji
- Huguenard, John
- Pașca, Sergiu P.
- SpringerLink (Online service)
Other Objects (12)
Nonviral delivery systems for antisense oligonucleotide therapeutics
A gapmer antisense oligonucleotide targeting SRRM4 is a novel therapeutic medicine for lung cancer
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Pharmacological studies of antisense oligonucleotide microRNA inhibitors
Antisense Oligonucleotide-mediated exon skipping as a systemic therapeutic approach for recessive dystrophic epidermolysis bullosa
Profiled support vector machines for antisense oligonucleotide efficacy prediction
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
The potential of antisense oligonucleotide therapies for inherited childhood lung diseases
CD47 antisense oligonucleotide treatment attenuates obesity and its-associated metabolic dysfunction
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)
Nonviral delivery systems for antisense oligonucleotide therapeutics
A gapmer antisense oligonucleotide targeting SRRM4 is a novel therapeutic medicine for lung cancer
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Pharmacological studies of antisense oligonucleotide microRNA inhibitors
Antisense Oligonucleotide-mediated exon skipping as a systemic therapeutic approach for recessive dystrophic epidermolysis bullosa
Profiled support vector machines for antisense oligonucleotide efficacy prediction
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
The potential of antisense oligonucleotide therapies for inherited childhood lung diseases
CD47 antisense oligonucleotide treatment attenuates obesity and its-associated metabolic dysfunction
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)
Nonviral delivery systems for antisense oligonucleotide therapeutics
A gapmer antisense oligonucleotide targeting SRRM4 is a novel therapeutic medicine for lung cancer
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Pharmacological studies of antisense oligonucleotide microRNA inhibitors
Antisense Oligonucleotide-mediated exon skipping as a systemic therapeutic approach for recessive dystrophic epidermolysis bullosa
Profiled support vector machines for antisense oligonucleotide efficacy prediction
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
The potential of antisense oligonucleotide therapies for inherited childhood lung diseases
CD47 antisense oligonucleotide treatment attenuates obesity and its-associated metabolic dysfunction